To Congress
Before the next pandemic — which experts tell us is a matter of when, not if — pass legislation requiring companies that get federal support for biomedical research and development to price their products reasonably and affordably. The American people should never again be subject to the price-gouging, double-dipping, and extortionate profiteering of Big Pharma — especially not during or after a pandemic and not for treatments developed with public funding.